Course opens: 
01/01/2016

Aventura, FL – October 20-22, 2017

Aventura, FL US
October 20, 2017 to October 22, 2017

This practice-based activity will provide the compounding technician with a strong foundation and skill set required to perform day-to-day activities surrounding the safe handling, management, and compounding of non-hazardous and hazardous medications. The practicing technician will relate dosage form composition to formulation preparatory procedures and techniques. Excipient function(s) and their impact on chemical composition, dosage form integrity, and suitability for a patient will be reviewed.

Relationships will be established between quality initiatives and System P (a compounding practice infrastructure, which include Personnel, Property, Procedure, Process, Preparation, and Patient). The value of thinking, and taking action, from the perspectives of quality, risk, and verification will also be explored. Standard operating procedure requirements and their associated recording logs and forms will be detailed. Meaningful interpretations, subsequent to data mining from logs and forms will be created, providing insight into the value of maintaining accurate and complete records.  Technicians will establish and then evaluate facility designs for their workflow efficiencies. During this experience, the technician will gain knowledge and perception of when and where tasks and procedures should be performed.

Finally, the technician will work with and complete a master formulation record. These records will then be critiqued by others. This is a valuable exercise while working with one of the most important documents that technicians will follow and detail during their day-to-day activities within a non-sterile compounding practice.


Intended audience


Technicians new to non-sterile compounding.


Learning Objectives

FOR TECHNICIANS:
  1. Support the detailed requirements necessary to build efficient and effective standard operating procedures to manage a non-sterile non-hazardous and/or non-sterile hazardous drug compounding practice.
  2. Support the quality, risk, and verification initiatives held by a compounding pharmacy as a foundation for excellence in support of the integrity of the compounding industry.
  3. Create relationships between control, perform, verify, and document against the six categories of System P: personnel, property, procedure, process, preparation, and patient.
  4. Value and evaluate the data from recordings from logs and forms related to standard operating procedures, a shared responsibility between pharmacist and technician.
  5. Assess workflow dynamics-related considerations, should the technician wish to make recommendations for change, as it applies to facility design requirements for non-hazardous and hazardous drug compounding.
  6. Construct relationships between routes of delivery, chemical composition, and preparatory procedures for non-sterile dosage forms, so as to gain an appreciation for the preparatory procedures and excipient requirements of a compounded medication.
  7. Support the transition from process development, to master formulation record, to compounding record through the use of a template designed to incorporate the parameters for all three formulation stages.
  8. Prepare a broad range of non-sterile dosage forms: hydro-alcoholic gels, lollipops, chewable treats for animals, capsules, troches, suppositories, and creams.
  9. Evaluate compounded dosage forms through the use of specific verification protocols in compliance with current standards of practice, including qualitative and quantitative performance measures.

Financial support: 


An unrestricted educational grant has been provided by MEDISCA Inc.


 

CURRENT PROMOTIONS:

20% Off

Use coupon code 20LP317 upon checkout to receive 20% off this educational training. 

 

Course summary
Available credit: 
  • 4.00 CEU (ACPE)
  • 40.00 Contact Hours
Event starts: 
10/20/2017 - 8:00am
Event ends: 
10/22/2017 - 2:30pm
LP3 Network Facility
21550 Biscayne Blvd
Suite 300
Aventura, FL 33180
United States
Price:
$2250.00
LP3 Network Facility
21550 Biscayne Blvd
Suite 300
Aventura, FL 33180
United States

Hotel information: 


The preferred hotel accommodation is the Hampton Inn Hallandale Beach Aventura.

Please mention LP3 Network when booking to get our special group rate of $119/night for a Double room (please check your registration email for the corporate rate code).

For reservations, please call 1-888-871-3430 or to book online, click here.

 

Based on Availability. Payment for hotel accommodations is at the expense of the activity participant. 

 

Hotel Location: 
Hampton Inn Hallandale Beach Aventura
1000 South Federal Highway
Hallandale Beach, FL 33009
United States

KENNETH LATTA, BS Pharm, RPh, FIACP, FACA
Senior Associate, Gates Healthcare Associates
Disclosure: Health System Consulting Group LLC, Co-Owner and Consultant; Gates Healthcare Associates, Consultant; Accreditation Commission for Health Care/Pharmacy Compounding Accreditation Board, Surveyor; North Carolina Board of Pharmacy, Consultant; Visante UK, Consultant; Visante, Consultant; MEDISCA, Consultant

MARK FILOSI, BS Pharm, RPh
Compounding Pharmacist and Co-Founder, Family Care Pharmacy
Disclosure: Accreditation Commission for Health Care, Surveyor; MEDISCA, Consultant

MICHAEL SHAFOR, BSc, PharmD
IV Oncology, IV Home Health Specialist, and Clinical Pharmacy Manager, Oncology Plus Inc.
Disclosure: None
image


Note: Facilitators are subject to change. 


Editors

NEIL COHEN, BSc
CE Program Developer
Disclosure: MEDISCA, Consultant
DAPHNEE LALONDE, BSc, MSc
Continuing Education Supervisor
Disclosure: MEDISCA, Consultant


CONTRIBUTORS:
 

MARK FILOSI, BS Pharm, RPh
Compounding Pharmacist and Co-Founder, Family Care Pharmacy
Disclosure: Accreditation Commission for Health Care, Surveyor; MEDISCA, Consultant

JOE CABALEIRO, BS Pharm, RPh
Senior Associate, Gates Healthcare Associates
Disclosure: Accreditation Commission for Health Care, Consultant; Gates Healthcare Associates, Consultant; Healthrx Group, Consultant; MEDISCA, Consultant

 

Total CPE Credits (home study and live activity): 40 CPE Hours = 4.0 CEUs
Joint Accreditation Status (University of Florida College of Pharmacy / LP3 Network)

Home study activity type: Knowledge-based
Home study UAN: 0012-9999-16-011-H04-T
Home study CPE credits: 20 CPE hours = 2.0 CEUs
Release date: January 1st, 2016
Expiration date: January 1st, 2019

Live activity type: Practice-based
Live activity UAN: 0012-9999-16-012-L04-T
Live activity CPE credits: 20 CPE Hours = 2.0 CEUs
Release date: January 1st, 2016
Expiration date: January 1st, 2019

To receive CPE credits for the home study, participants must complete a learning assessment with a score of 70% and submit a completed evaluation to the University of Florida College of Pharmacy. To receive CPE credits for the live activity, participants must demonstrate full and satisfactory participation, and submit a completed evaluation to the University of Florida College of Pharmacy.

Participants registered in the United States can obtain a statement of credit from their NABP e-Profile. The University of Florida College of Pharmacy will report CPE credits to the CPE Monitor. Participants registered other than in the United States will receive a statement of credit by email.


International participants should verify with their respective governing board for accreditation equivalency. 

CURRENT PROMOTIONS:

20% Off

Use coupon code 20LP317 upon checkout to receive 20% off this educational training. 

 

Price

Price:
$2250.00
Please login to Enroll or Add to Waitlist
Cancellation and refund policy: 


A written request must be sent to LP3 Network requesting “Cancellation without Transfer” to an alternate live activity date. If cancellation occurs at greater than or equal to 31 days from the live activity date, then the registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund.


TRANSFER POLICY:

The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.


 

Course expires: 
01/01/2019